Microsoft word - hair loss medication in detail

Hair Loss Medication in Detail
Finastride
Generically named Propecia and also Proscar was developed to treat benign prostatic hyperplasia as a DHT
inhibitor. It was then found to be successful in treating mild to moderate male pattern hair loss on the
vertex (top of head) and anterior mid-scalp area (middle front of head) in men only and should not be
used by women or children. There is not sufficient evidence that PROPECIA works for receding hairlines
at the temples.
Side Effects were uncommon and did not affect most men
Although rare a small number of men had sexual side effects, with each occurring in less than 2% of men. These included a loss of libido, difficulty in achieving an erection, and a decrease in the amount of semen. These side effects went away in men who stopped taking Finestride. In addition, these side effects decreased to 0.3% of men or less by the fifth year of treatment. 1) Can falsify a PSA test (prostate- specific antigen) used to detect prostate cancer. 2) Allergic reaction symptoms in the form of; rash, hives, swelling of the lips and face, breast tenderness and enlargement and testicular pain. Any side effects should be reported to your physician immediately. It generally takes up to 3 months to see any hair growth. Once you stop taking Propecia the hair loss will once again progress and return to its original state within 12 months. Dutasteride
AVODART reduces serum DHT in a rapid and consistent manner within 1 to 2 weeks. In clinical studies, after 1 and 2 weeks of daily dosing with AVODART 0.5 mg, median serum DHT concentrations were reduced by 85% and 90%, respectively. In patients with BPH treated with AVODART 0.5 mg/day for 2 years, the median decrease in serum DHT was 94% at 1 year and 93% at 2 years. Physicians should also inform patients that there may be a decrease in ejaculate volume in some men taking AVODART. This effect does not appear to interfere with normal sexual function. In clinical trials, the incidence of impotence and decreased libido, considered by investigators to be drug-related, was 5% with AVODART and 3% with placebo. SIDE EFFECTS
Clinical trials showed that it was generally well tolerated. Most side effects were mild or moderate and generally went away while on treatment in both the Avodart and placebo groups. Drug-related side effects during the first six months were as follows: impotence (4.7 percent vs. 1.7 percent for placebo), decreased libido (3 percent vs. 1.4 percent), breast tenderness and breast enlargement (gynecomastia; 0.5 percent vs. 0.2 percent) and ejaculation disorders (1.4 percent vs. 0.5 percent). The incidence of most drug-related sexual side effects decreased with duration of treatment. The incidence of drug-related breast tenderness and breast enlargement remained constant over the treatment period. Ejaculate volume may be decreased in some patients with continued treatment. This decrease did not appear to interfere with normal sexual function. Rogaine (minoxidil)
Minoxidil was initially developed to be taken orally for the treatment of high blood pressure. A side effect from taking the medication was hair growth at which time the drug was changed to a topical application. The action of Rogaine is that of a vasodilator which tends to increase circulation in the tissue it is applied to. With hair loss as we know there is a miniaturization of the hair follicles partly due to the action DHT and also due to atrophy of the vascular beds providing nutrition to the follicle. With gradual starving of the follicle the hair produced undergoes miniaturization until ultimately the hair just does not regrow. Rogaine's action as a vasodilator improves the circulation and nutrition of the hair follicle and thus strengthens existing hair. The resultant hair growth while using Rogaine will reverse once treatment is stopped and one again the hair follicle will undergo miniaturization and will cease to grow. Use after Transplant - Many transplant surgeons recommend using Rogaine immediately after surgery in order to assist revascularizing the transplanted follicles. This vascularization will also help reduce the amount of shock hair loss from the follicles which exist around the hair transplant site. Recommended usage is up to the physician. Side Effects
• unwanted facial hair growth (especially in women) Natural Hair Loss Products
Listed in the table below is a comparison of the four most popular natural hair loss products currently be marketed. These products are manufactured from natural occurring ingredients and thereby resulting in a reduced possibility of developing any side effects. In fact the majority of these products can be utilized by men and women and also offer a customer satisfaction guarantee. Revivogen NewHair
Proguard Procerin
Biofactors
Trade Name
Revivogen Nisim
Proguard
Procerin
Biofactors
Manufacturer Advanced Skin and
dermatologist as a natural alternative to medical management of hair loss without side effect. Ingredients Gamma
Linolenic
Saw palmetto,
Saw palmetto,
Saw Palmetto
acid (GLA), Alpha
amino acids
Berries, Gotu Kola,
Linolenic acid (ALA),
Africanum
Nettles,
Linoleic Acid, Oleic
and methionine), Extract, Urtica
Magnesium, Zinc
Acid are fatty acids
B-vitamins
Dioica Extract,
Sulfate, Siberian
Green Tea
Ginseng, Vitamin
Extract,
B-6, Pumpkin
OptiZinc,
Seed Meal, CJ-11
Pyridoxine
Factor, CJ-9
Azaleic acid, Vitamin
Hydrochloride
Factor, and Mura
B6 and Zinc are also
(Vitamin B6),
Puma Root
Magnesium
Saw Palmetto know
men whose hair is no longer in a growth phase is Beta-Sitosterol and
Procyanidin
Oligomers
possess growth stimulation activity toward hair epithelial cells in vitro and stimulate anagen induction in hair follicles in vivo inhibits DHT formation. thereby reducing further loss of hair from the scalp, without causing the sexual side effects of prescription drugs like finasteride (Propecia). Alternative
Women
Duration for
Result
Cost
More Info
www.revivogen.com www.herbalsens
www.folica.co
www.procerin.co
ations.com

Source: http://www.truehair.ca/pdfs/articles/Hair%20Loss%20Medication%20in%20Detail.pdf